Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Kymera Therapeutics

Request full access

A biotechnology company pioneering a transformative new approach to treating previously untreatable diseases

Cambridge, United StatesFounded 2016Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2020

Kymera Therapeutics in the Cambridge ecosystem

Live from Dealroom

The Kymera Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later9 investors entered at this stage

Employees mapped 306 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$28M

98 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Kymera Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.